Correlation Between Intracellular and Dynavax Technologies

Can any of the company-specific risk be diversified away by investing in both Intracellular and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intracellular and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Intracellular Th and Dynavax Technologies, you can compare the effects of market volatilities on Intracellular and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intracellular with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intracellular and Dynavax Technologies.

Diversification Opportunities for Intracellular and Dynavax Technologies

0.21

Correlation Coefficient

Intracellular  Dynavax Technologies

Modest diversification

The 3 months correlation between Intracellular and Dynavax is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Intracellular Th and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Intracellular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intracellular Th are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Intracellular i.e., Intracellular and Dynavax Technologies go up and down completely randomly.

Pair Corralation between Intracellular and Dynavax Technologies

Given the investment horizon of 90 days Intracellular Th is expected to generate 4.12 times more return on investment than Dynavax Technologies. However, Intracellular is 4.12 times more volatile than Dynavax Technologies. It trades about 0.16 of its potential returns per unit of risk. Dynavax Technologies is currently generating about 0.07 per unit of risk. If you would invest  8,565  in Intracellular Th on November 29, 2024 and sell it today you would earn a total of  4,281  from holding Intracellular Th or generate 49.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Intracellular Th  vs.  Dynavax Technologies

Intracellular Th

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Intracellular Th are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Intracellular demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Dynavax Technologies

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Dynavax Technologies is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Intracellular and Dynavax Technologies

The main advantage of trading using opposite Intracellular and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intracellular position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.

The idea behind Intracellular Th and Dynavax Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.